-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

621.O1.6 621. Hodgkin Lymphoma: Biology, excluding Therapy: Biological Insights and Clinical Impact

Hodgkin Lymphoma: Biology, excluding Therapy Program: Oral and Poster Abstracts
Type: Oral
Sunday, December 6, 2015: 7:30 AM-9:00 AM
W307, Level 3 (Orange County Convention Center)
Moderators:
Peter Vandenberghe, MD PhD, University Hospitals Leuven and David W Scott, MBChB, PhD, British Columbia Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology

Disclosures:
No relevant conflicts of interest to declare.
7:30 AM

Anja Mottok, MD1,2, Rebecca Lea Johnston1,3*, Fong Chun Chan, MSc1,3*, David W Scott, MBChB, PhD1,4, Debra L. Friedman, MD, MS5, Cindy Schwartz, MD6, Kara M. Kelly, MD7, Terzah M. Horton, MD, PhD8 and Christian Steidl, MD1,2

1Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada
2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada
3Bioinformatics Training Program, University of British Columbia, Vancouver, BC, Canada
4Department of Medicine, University of British Columbia, Vancouver, BC, Canada
5Vanderbilt-Ingram Cancer Center, Nashville, TN
6MD Anderson Cancer Center, Houston, TX
7Pediatric Hematology/Oncology/Stem Cell Transplantation, Columbia University Medical Center, New York, NY
8Pediatrics, Hematology/Oncology, Baylor College of Medicine, Houston, TX

7:45 AM

Margaretha GM Roemer, MS1*, Ranjana H Advani, MD2, Azra H. Ligon, PhD3*, Yasodha Natkunam, MD, PhD2, Robert A Redd, MS4*, Heather Homer1*, Courtney Connelly5*, Heather H. Sun3*, Sarah E. Daadi2*, Bjoern Chapuy, MD, PhD1, Daphne de Jong, MD, PhD6*, Richard T. Hoppe, MD2, Donna S Neuberg, ScD7, Scott J Rodig, MD, PhD3 and Margaret A. Shipp, MD5

1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
2Stanford University Medical Center, Stanford, CA
3Pathology, Brigham and Women's Hospital, Boston, MA
4Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA
5Dana-Farber Cancer Institute, Boston, MA
6Pathology, VU University Medical Center, Amsterdam, Netherlands
7Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA

8:00 AM

Hans Knecht, MD1, Nathalie Johnson, MD, PhD1, Tina Petrogiannis-Haliotis, MD, PhD2*, Daniel Lichtensztejn3* and Sabine Mai, PhD3*

1Hematology, Jewish General Hospital, McGill University, Montreal, QC, Canada
2Pathology & Hematology, Jewish General Hospital, McGill University, Montreal, QC, Canada
3GCCRD, MICB, University of Manitoba, Winnipeg, MB, Canada

8:15 AM

Elena Mata, Dr.1*, Antonio Díaz-López, Dr.1*, Ana M Martín-Moreno, Dr.2*, Carlos Montalbán, MD PhD3*, Maria J Mestre, Dr.4*, Carlos Santonja, Dr.5*, Fernando Burgos, Dr.6*, Javier Menárguez, Dr.7*, Miguel A Piris, Dr.8 and Juan F García, Dr.2*

1Translational Research, MD Anderson Cancer Center Madrid, Madrid, Spain
2Pathology, MD Anderson Cancer Center Madrid, Madrid, Spain
3Hematology, MD Anderson Cancer Center Madrid, Madrid, Spain
4Pathology, Hospital U. Móstoles, Móstoles, Spain
5Pathology, Hospital Infanta Sofía, San Sebastián de los Reyes, Spain
6Pathology, Hospital Severo Ochoa, Leganés, Spain
7Pathology, Hospital G.U. Gregorio Marañón, Madrid, Spain
8Pathology, Hospital Marques de Valdecilla, Santander, Spain

8:30 AM

Jun Wang, Ph.D.1*, Amie Hwang, PhD, MPH2, Dan Weisenberger, Ph.D.3*, David J. Van Den Berg, Ph.D.4,5*, Victoria K. Cortessis, Ph.D.6*, Marta Epeldegui, Ph.D.7*, Otoniel Martinez-Maza, PhD8*, Timothy Junius Triche Jr., PhD9, Ann S. Hamilton, Ph.D.2*, Bharat N. Nathwani, M.D.10, David V. Conti, Ph.D.6*, Steve Horvath, Ph.D., Sci.D.7*, Thomas M. Mack, M.D., M.P.H.6* and Wendy Cozen, DO, MPH11

1University of Massachusetts School of Public Health, Amherst, MA
2Keck School of Medicine at USC, University of Southern California, Los Angeles, CA
3USC Epigenome Center, Keck School of Medicine of USC, University of Southern California, Los Angeles
4USC Norris Comprehensive Cancer Center, Department of Preventive Medicine, USC Keck School of Medicine, University of Southern California, Los Angeles, CA
5University of Southern California Epigenome Center, Los Angeles, CA
6Keck School of Medicine of USC, University of Southern California, Los Angeles, CA
7David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA
8Department of Gynecology & Obstetric, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA
9Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, University of Southern California, Los Angeles, CA
10Department of Pathology, City of Hope Medical Center, Duarte, CA
11Preventive Medicine and Pathology, Keck School of Medicine and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA

8:45 AM

Alison J Moskowitz, MD1, Sun Cho2*, Martin Fleisher, PhD2*, Kaitlin M Woo, MS3*, Zhigang Zhang, PhD3*, Stephanie Fox2*, Susan J McCall, MSN ANP-BC2*, Heiko Schoder, MD2*, Joachim Yahalom, MD2* and Craig H Moskowitz, MD4

1Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
2Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
4Department of Medicine, Lymphoma and Adult BMT Services, Memorial Sloan Kettering Cancer Center, New York, NY

*signifies non-member of ASH